These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26822064)

  • 1. Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review.
    Bo QJ; Wang ZM; Li XB; Ma X; Wang CY; de Leon J
    Psychiatry Res; 2016 Mar; 237():257-63. PubMed ID: 26822064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials.
    Zheng W; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang N; Ning YP; Xiang YT
    J Psychopharmacol; 2017 May; 31(5):625-631. PubMed ID: 28372526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia.
    Krysiak R; Kowalcze K; Szkrobka W; Okopien B
    Eur J Intern Med; 2016 May; 30():94-98. PubMed ID: 26858210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.
    Li X; Tang Y; Wang C
    PLoS One; 2013; 8(8):e70179. PubMed ID: 23936389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study.
    Yoon HW; Lee JS; Park SJ; Lee SK; Choi WJ; Kim TY; Hong CH; Seok JH; Park IH; Son SJ; Roh D; Kim BR; Lee BO
    Clin Neuropharmacol; 2016; 39(6):288-294. PubMed ID: 27438182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.
    Rusgis MM; Alabbasi AY; Nelson LA
    Am J Health Syst Pharm; 2021 May; 78(10):862-871. PubMed ID: 33954421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders.
    Takechi K; Yoshioka Y; Kawazoe H; Tanaka M; Takatori S; Kobayashi M; Matsuoka I; Yanagawa H; Zamami Y; Imanishi M; Ishizawa K; Tanaka A; Araki H
    Biol Pharm Bull; 2017; 40(10):1775-1778. PubMed ID: 28966250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole for the treatment of duloxetine-induced hyperprolactinemia: A case report.
    Luo T; Liu QS; Yang YJ; Wei B
    J Affect Disord; 2019 May; 250():330-332. PubMed ID: 30875676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
    Roke Y; van Harten PN; Boot AM; Buitelaar JK
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
    Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
    J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review.
    Druyts E; Zoratti MJ; Toor K; Wu P; Kanji S; Rabheru K; Mills EJ; Thorlund K
    BMC Pediatr; 2016 Nov; 16(1):181. PubMed ID: 27825323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of psychotropic-induced hyperprolactinemia.
    Marken PA; Haykal RF; Fisher JN
    Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
    Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
    J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.